Back to search
Chronic Pulmonary Aspergillosis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Chronic Pulmonary Aspergillosis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Chronic Pulmonary Aspergillosis trials you may qualify forWhile ABPA and CPA represent two distinct manifestations of Aspergillus-related lung disease, there is an overlap of investigations that are currently used for…
The goal of this study is to learn how the body's immune system affects disease control in people with different airway inflammatory diseases.We want to underst…
The goal of this clinical trial is to to evaluate the drug rezafungin in the treatment of Chronic Pulmonary Aspergillosis (CPA) in male and female patients aged…
This is a single center open-label feasibility trial involving a single study visit for participants. The purpose of the study is to demonstrate the feasibility…
To develop and validate a novel disease-specific questionnaire for measuring HRQoL in patients with Chronic Pulmonary Aspergillosis (CPA-HAQ) for use in clinica…
This study explores the role of treatment with interferon-gamma to improve outcomes in chronic pulmonary aspergillosis (CPA). CPA is a progressive infection cau…
This study evaluates and aims to optimize inhalation treatment with nebulized liposomal amphotericin B in patients with chronic pulmonary aspergillosis. The pri…
The goal of the study is to determine whether vitamin D levels are associated with cytokine profiles in patients with pulmonary tuberculosis, including those wi…
Allergic Bronchopulmonary Aspergillosis is a rare pulmonary disease involving allergic mechanisms, which historically affects patients with asthma or cystic fib…